Insiders · Profile

Rajangam Kanya

Pres. & Chief Med. & Dev. Off. at Senti Biosciences · Chief Medical Officer at Nkarta. Filing since 5 Aug 2021. CIK 0001816676

Company

Date

Role

Action

Amount

Of holding

6 Feb 2025

Pres. & Chief Med. & Dev. Off.

Sold at will

182

$795.34

2.1%

4 Feb 2025

Pres. & Chief Med. & Dev. Off.

Sold at will

1,297

$5.28K

12.8%

5 Aug 2021

Chief Medical Officer

Sold, plan not stated

10,000

$372.80K

100%

3 decisions on file.